Transforming pharmacovigilance with a technology-driven intelligent model

Digital technologies are being increasingly leveraged in the processing and handling of safety cases due to the advancement of novel, intelligent and automated pharmacovigilance (PV) platforms. The rapid development of these platforms has enabled the processing of safety report volumes in an extremely short period with reduced efforts, leading to improved safety analysis and regulatory compliance.

However, the adoption and shift from traditional pharmacovigilance model of mostly manual interventions to a next-gen AI/ML-based, automated and intelligent model represents technical challenges and organizational changes for the industry. The agile and decentralized nature of the next-gen pharmacovigilance approach brings in quality, efficiency, and more importantly, organizational adaptation that helps the industry to not only withstand but prosper amidst ever-evolving business and responsibility paradigms.